Cigna Group — Regulatory Filings 2021

Apr 7, 2021

DEFA14A 1 nc10022778x1_defa14a.htm DEFA 14A Licensed to: Broadridge Financial Solutions, Inc. Document created using EDGARfilings PROfile 7.4.0.0 Copyright 1995 - 2021 Broadridge Begin Page 1

Anchor

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of

the Securities Exchange Act of 1934 (Amendment No. )

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐ Preliminary Proxy Statement

☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

☐ Definitive Proxy Statement

☒ Definitive Additional Materials

☐ Soliciting Material under Sec. 240.14a-12

Cigna Corporation

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

☒	​	​	No fee required.
	​	​
☐	​	​	Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
	​	​		​	​
	​	​	(1)	​	​	Title of each class of securities to which transaction applies:
	​	​		​	​
	​	​	(2)	​	​	Aggregate number of securities to which transaction applies:
	​	​		​	​
	​	​	(3)	​	​	Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
	​	​		​	​
	​	​	(4)	​	​	Proposed maximum aggregate value of transaction:
	​	​		​	​
	​	​	(5)	​	​	Total fee paid:
	​	​		​	​
	​	​		​	​
☐	​	​	Fee paid previously with preliminary materials.
	​	​		​	​
☐	​	​	Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
	​	​		​	​
	​	​	(1)	​	​	Amount Previously Paid:
	​	​		​	​
	​	​	(2)	​	​	Form, Schedule or Registration Statement No:
	​	​		​	​
	​	​	(3)	​	​	Filing Party:
	​	​		​	​
	​	​	(4)	​	​	Date Filed:
	​	​		​	​

End Page 1

Begin Page 2

Anchor

April 7, 2021

Dear Shareholder:

We have previously sent to you proxy materials for the Cigna Corporation Annual Meeting of Shareholders to be held on April 28, 2021. To date, we have not received your proxy. Your Board of Directors unanimously recommends that you vote FOR all of the nominees for director in Proposal 1, FOR Proposals 2, 3 and 4, and AGAINST Proposals 5, 6 and 7.

Your vote is important , no matter how many or how few shares you may own. To ensure that your shares are represented at the meeting, please vote today by telephone, via the Internet, or by signing, dating and returning the enclosed proxy card in the envelope provided.

Very truly yours,

/s/ Julia Brncic

Julia Brncic

Corporate Secretary

​	REMEMBER:	​
​	You can vote your shares by telephone or via the Internet.	​
​	Please follow the easy instructions on the enclosed proxy card.	​
​	If you have any questions or need assistance in voting	​
​	your shares, please call our proxy solicitor,	​
​		​
​	INNISFREE M&A INCORPORATED	​
​	TOLL-FREE, at 1-877-800-5186	​

End Page 2